Pertussis toxin inhibits the N-formyl-MetLeu-Phe (fMet-Leu-Phe) mediated human neutrophil functions of enzyme release, superoxide generation, aggregation, and chemotaxis. As pertussis toxin modifies the GTP binding receptor-regulatory protein "N1," the association of the fMetLeu-Phe receptor with such a protein was further examined in purified neutrophil plasma membranes. Both fMet-Leu-Phemediated guanine nucleotide exchange and nucleotide-mediated regulation of the fMet-Leu-Phe receptor are inhibited by pertussis toxin. In addition, membrane pretreatment with pertussis toxin abolishes the fMet-Leu-Phe-mediated inhibition of adenylate cyclase. Actions of pertussis toxin are due to the ADP-ribosylation of a single subunit at 41 kDa in the neutrophil plasma membrane, which comigrates on NaDodSO4 gels with the N. GTP-binding protein in the platelet plasma membrane. Our results suggest that (i) the fMet-Leu-Phe receptor is associated with a N. GTP regulatory protein, and (it) a fMetLeu-Phe-N; complex is important in the control of several neutrophil functions, probably involving multiple transduction systems, including adenylate cyclase.
METHODS
Neutrophil Plasma Membranes. Human neutrophils were isolated on dextran and Ficoll-Hypaque gradients and plasma membranes were prepared as described (7) . The structural characteristics of the native and toxin-treated membranes were determined by NaDodSO4 gel electrophoresis, using the system of Neville (7, 14) . Adenylate cyclase activity was determined by the assay of Salomon et al. (15) at an ATP concentration of 50 uM. Details of the assay are provided elsewhere (6, 7) .
Toxin Activation, Membrane Labeling, and Whole Cell
Modification. PT (1 ,ug/ml) was activated by incubating with 0.1 M dithiothreitol for 15 min at 30'C (9) . The membrane (100 ,ug) was incubated with 100 mM nicotinamide/1 mM GTP/1 mM ADP-ribose/[32P]NAD (200 Ci/mmol; 1 Ci = 37 GBq)/5 ,ul of activated PT, in a final assay vol of 100 ,l for 30 min at 30'C. Samples were centrifuged at 200,000 x g for 15 min and prepared for NaDodSO4 gels. Whole cell treatments with PT were carried out by incubating the neutrophils (1-5 x 107 cells per ml) with PT (1-10 ,ug/ml) for 1 hr at 37°C. After the treatment, cells were pelleted (400 x g for 15
Abbreviations: fMet-Leu-Phe, N-formyl-L-methionyl-L-leucyl-Lphenylalanine; PT, pertussis toxin; GuoPP[NH]P, 5'-guanylyl imidodiphosphate.
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min) and resuspended in Hanks' balanced salt solution at a concentration of 2 x 107 cells per ml and were evaluated for various neutrophil functions. Controls for membrane pretreatment included incubation with buffer alone (without PT) and incubation with PT in the absence of NAD. A control for the whole cell treatment consisted of treatment with buffer alone under identical incubation conditions. Cell viability was checked routinely, using trypan blue exclusion. Viability of >95% was observed in both PT-treated and control cells.
Chemotaxis This mixture was then added to 2.9 ml of pre-equilibrated (30°C) buffer A containing the ligands and unlabeled nucleotide, and was incubated for 10 min. The exchange was terminated by rapid vacuum filtration over Whatman GF/C filters, using a Millipore filtration manifold, and the filtrate activity was counted in 12 ml of Hydrofluor in a Beckman LS-7500 liquid scintillation counter.
[3H fMet-Leu-Phe Binding. Neutrophil membranes (25,ug per assay in a total vol of 200 ,lI) were incubated with
[3H]fMet-Leu-Phe (1.1 nM; 78.4 Ci/mmol) for 30 min at 25°C in Hanks' balanced salt solution (10) . The incubation was terminated by the addition of 4 ml of ice-cold incubation buffer and then filtered over GF/C filters in a Millipore apparatus. The filters were washed twice with 4 ml of ice-cold incubation buffer. The filters were dried, transferred to scintillation vials, and the membrane was solubilized in 2 ml of NCS tissue solubilizer overnight at room temperature. Omnifluor scintillant (15 ml) was added to the vials, and the activity was measured in a Beckman LS-7500 counter.
Other Neutrophil Function Tests. Aggregation studies were carried out as described by Craddock et al. (18) . Enzyme (lysozyme) release was measured using the method of Zurier et al. (19) . The percent lysozyme released was 35%-40% of the total measured in the presence of 0.5% Triton X-100. Superoxide generation was monitored as the reduction of cytochrome c (20) . Controls included cells incubated without substrate and cells incubated with fMet-Leu-Phe and superoxide dismutase.
RESULTS
As shown in Fig. 1 , PT inhibits fMet-Leu-Phe modulation of diverse neutrophil functions. For example (Fig. 1A) , the aggregation profiles of control and toxin treated cells are shown at fMet-Leu-Phe concentrations of 10 and 100 nM. At 10 nM fMet-Leu-Phe, significant inhibition and reversibility of aggregation is observed in toxin-treated cells. At a higher concentration (100 nM), the degree of inhibition is lower. When fMet-Leu-Phe-mediated chemotaxis was examined (Fig. 1B) , a near complete inhibition (>90%) of chemotactic response was observed at all concentrations of fMet-LeuPhe tested (1-100 nM). Analysis of fMet-Leu-Phe-mediated superoxide generation and enzyme release (Fig. 1C) showed a pattern of inhibition that was very similar to the pattern observed for inhibition of aggregation. Maximal and nearcomplete inhibition relative to control cells was observed at 10 nM fMet-Leu-Phe, while only 30%-40% of maximal inhibition is observed at 100 nM fMet-Leu-Phe. In summary, the results indicate that PT is a potent inhibitor of fMet-LeuPhe-mediated cellular response at low concentrations of fMet-Leu-Phe in aggregation, enzyme release, and superoxide production, as well as a potent inhibitor of chemotaxis at all concentrations tested. The difference in the mode of inhibition between these two sets of responses is unclear, although it is worth noting that cytochalasin B is present in those function tests in which an inverse relationship between the degree of inhibition and fMet-Leu-Phe concentration is observed.
The significant inhibition of diverse functions by PT implies a target for this toxin proximal to the receptor itself. It is now well established that PT modifies the N. component of adenylate cyclase (8, 9) . The role for a Ni protein in the human neutrophil was probed by examining the effects of PT on two characteristic regulatory processes that involve GTP regulatory proteins: (i) GTP-mediated regulation of the receptor and (ii) receptor-mediated release of prebound labeled guanine nucleotide. The results presented in Figs. 2 and 3 show that both guanine nucleotide regulation of the fMet-Leu-Phe receptor as well as fMet-Leu-Phe-mediated guanine nucleotide release occur in neutrophil plasma membranes. Consistent with its observed role as an "uncoupler" of receptor-Ni interactions (8) , PT caused significant inhibition in both of these regulatory processes. Nucleotide release was observed in a dose-dependent manner in the presence of fMet-Leu-Phe (1 nM to 10 ,uM) for control membranes, while membranes treated with PT exhibited a 60% decrease in fMet-Leu-Phe-mediated exchange. PT modification also affects the GTP-binding protein directly, asthe bas- (A) Neutrophil aggregation was carried out as described. In the experiments 1 x 106 cells were used at fMet-Leu-Phe doses of 10 (lower curves) and 100 nM (upper curves). The aggregation response is essentially complete in 3-4 min. PT nucleotide that accompanies the abolition of the effect of fMet-Leu-Phe on nucleotide exchange. Alterations in the levels of the hormone and of nucleotide binding have also been noted in the actions of cholera toxin on the N, component (12) , and similar considerations may apply to the actions of PT on Ni.
The target enzyme for a fMet-Leu-Phe-Nj complex was then considered. An obvious choice involves the N1-mediated inhibition of adenylate cyclase (Fig. 4) , which was tested in the presence of forskolin, in both whole homogenates and purified plasma membranes, to permit easier detection of inhibition through enhanced basal activity. Inhibition of cyclase was also tested in the presence of prostaglandin E1/GTP (data not shown). fMet-Leu-Phe-mediated inhibition of cyclase was observed with both preparations in the presence of forskolin and prostaglandin E1/GTP. However, fMet-Leu-Phe-mediated inhibition was observed at higher concentrations of fMet-Leu-Phe (ED50, 1 ,4M) than required for maximal cellular effects of this peptide (e.g., Fig. 1 ). PT modification of the membrane resulted in a clear abolition of the inhibitory phase, as observed in other N8 systems.
The molecular basis for the effects of PT were examined using [a-32P]NAD as the substrate. NaDodSO4 gel electrophoresis and autoradiography of the labeled membranes revealed a single band at 41 kDa (Fig. 5, lane 2) . This band comigrated with a band in human platelet membranes, isolated according to Barber and Jamieson (21) (12) .
The linkage of the fMet-Leu-Phe receptor with Ni raises a question regarding the role of such a complex in neutrophil function. Its relevance in regulating the human neutrophil is readily seen by the PT-mediated inhibition of several distinct fMet-Leu-Phe-mediated functions including chemotaxis, superoxide generation, enzyme release, and aggregation. The possibility that each response may show various degrees of susceptibility (as evidenced by distinct degrees of inhibition in Fig. 1 ) to the toxin needs to be examined in greater detail. The results suggest a target for the action of PT proximal to the receptor and, given the specific nature of the action of PT, also imply that the fMet-Leu-Phe-N, complex is central to the regulation of neutrophil functions.
The nature of the enzyme to which the fMet-Leu-Phe-Ni complex may be targeted is also considered here. Given the complex nature of the cellular reactions affected by PT and the large number of transduction systems proposed so far, (1, 2) a single unique target seems most unlikely. Of the possible targets mentioned in the literature, two of the most probable are adenylate cyclase-and calcium-mediated effects (22) (23) (24) (25) . In the present study, only the adenylate cyclase system has been examined, and it has been shown to be sensitive to PT. Such an association is in accord with both the role for Ni in the inhibition of other cyclase systems, and with the documented alterations in cAMP in the intact neutrophil (26), although the relationship of the biphasic cellular response to the effects in the isolated membrane need to be further investigated. Despite the overall compatibility of these observations, it is worth noting that the significance of fMet-Leu-Phe-mediated increases in cAMP for the regulation of cell function has been questioned (27) , implying that other transduction events may also be involved. fMet-LeuPhe receptor occupancy alters calcium gradients (24) and induces rearrangement of cytoskeletal elements (28) (29) (30) , with a secondary role indicated for cAMP (26, 27) . Thus, in addition to the modulation of adenylate cyclase, other transduction systems may also be modulated by a fMet-Leu-Phe-N, complex. These could include not only calcium-related effects (calcium fluxes and calcium redistribution) (22, 23) , but also changes in phospholipid metabolism and protease activation (1) . If the effects of fMet-Leu-Phe are directed through the N. protein, then such subsequent steps, primary or otherwise, should likewise be inhibited. A role for Mg2+ transport (31) has been demonstrated for the N, protein, in addition to, and distinct from, the role of N, in stimulating cyclase. Whether such a role is possible for Ni with respect to calcium is currently under investigation. Other receptors that modulate similar neutrophil functions (e.g., C5a and Fc) may also be regulated by N,. Preliminary experiments indicate that the effects on human neutrophils of zymosan-activated serum, the active component of which is CSa, on chemotaxis and aggregation seem to be affected by PIT. A more general pleiotropic role for Ni via the control of multiple receptors and transduction units in the regulation of the neutrophil and, perhaps, of other immune cells may become evident.
